Related Experiment Video
Updated: Apr 20, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Behçet's syndrome: pulmonary vascular disease
1aEmire Seyahi, MD: Professor, Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul, Istanbul, Turkey bHasan Yazici, MD: Professor, Division of Rheumatology, Department of Medicine, Cerrahpaşa Medical Faculty, University of Istanbul, Istanbul, Turkey.
Pulmonary artery involvement (PAI) in Behçet's syndrome includes aneurysms and thrombosis, often presenting with similar symptoms. While treatable with immunosuppressives, PAI can be fatal, necessitating further research into prediction and improved survival.
Area of Science:
- Vascular Medicine
- Rheumatology
- Pulmonary Medicine
Background:
- Pulmonary artery involvement (PAI) in Behçet's syndrome is a rare but significant condition.
- Interest in PAI spans multiple medical disciplines, including radiology, surgery, cardiology, and respiratory medicine.
- Recent advancements have reshaped the understanding of PAI's diverse manifestations.
Purpose of the Study:
- To review and synthesize current knowledge on pulmonary artery involvement in Behçet's syndrome.
- To highlight recent findings and changes in the understanding of PAI.
- To identify areas for future research in PAI.
Main Methods:
- Review of recent scientific literature on pulmonary artery involvement in Behçet's syndrome.
- Synthesis of findings related to PAI manifestations, clinical presentation, and outcomes.
- Analysis of associations between PAI and other thrombotic events.
Main Results:
- PAI encompasses not only aneurysms but also 'in-situ' pulmonary artery thrombosis (PAT), found in up to one-third of patients.
- Pulmonary artery aneurysms and PAT share clinical symptoms, though hemoptysis is less common in PAT.
- PAI is linked to deep vein thrombosis and right heart thrombosis, with associated pulmonary parenchymal lesions.
Conclusions:
- Despite improved understanding, predicting PAI development remains a challenge.
- Further research into the pathogenesis of PAI is crucial.
- Strategies to enhance patient survival require further investigation.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Portal Hypertension
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

